PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, November/December 2014

Issue link: http://dc.cn.ubm-us.com/i/431261

Contents of this Issue

Navigation

Page 16 of 43

17 November/December 2014 Pharmaceutical & Medical Packaging News • pmpnews.com more pervasive, demand for private brands will steadily come in from more sources, especially in mixed quantities or batches. Recent patent expirations and business growth have also contributed to the increased investment in private branding for generics. Small- to medium-sized distributors and pharmacies that serve clinics or hospital groups are capitalizing on this opportunity to establish a presence in their markets. Larger suppliers are turn- ing to smaller distributors and repack- ers for more-specialized products that are branded. With the growth of pri- vate labeling and branding, repackers are turning to technologies that can produce enhanced, custom color elements, while also developing durable, high-quality labels and logo variations efciently. Trends in serialization, dosage vari- ations, and user warnings at the state and federal levels, as well as new require- ments in global labeling standards, have contributed to the exponential growth of product label complexity. Signed into law a year ago, the DQSA regulations for the U.S. market call for itemized serialization and tracking of medications or medical products at every step of the manufactur- ing process—using unique labeling iden- tification. The prevailing prediction is that serial number tracking will move from case labels to individual package labels. This move adds more complexity since each package label will need to be uniquely printed. Global trade has also spurred the increase of multiple language require- ments in order to safely reach an expand- ing and changing consumer base. In North America alone, requirements have shifted to accommodate increas- ingly diverse and multilingual consumers. Canada's recent "Guidance Document Labelling of Pharmaceutical Drugs for Human Use" requires that drug labels be in both English and French (with the exception of open self-selection areas). On-demand color labeling enables rapid response to production chang- es that can be triggered by regulatory requirements, brand updates, product information, or shifts in language and messaging. Using a simplified one-step process of printing eliminates waste in time, investment, and materials such as unused pre-printed labels. Whether it is new serialization regulations or last- minute product brand changes, repackers and distributors require reliable technolo- gies that keep labeling operations simple and efcient. On-demand production is a necessary step for small- to medium-sized distributors and manufacturers, who are gradually shifting over to more flex- ible, high-quality technologies in order to meet consumer and industry demand. 0 © Copyright 2014 Packaging Coordinators, Inc. All Rights Reserved. Global Reach with 16 packaging facilities in North America and Europe Clinical Trial Services Manufacturing Services Commercial Services Laboratory Services www.pciservices.com One Expert Team Two Industry Leaders Have Joined Forces. PCI has joined forces with Penn Pharma to form a global leader in healthcare manufacturing and packaging services. With over 50 years of experience, an exemplary regulatory prof le, and an expert staff dedicated to delivering unparalleled service and quality, PCI leads the market in supporting clients' needs for innovative pharmaceutical outsourcing solutions. We've combined two exceptional and proven industry leaders into One Expert Team, One Partner for all your development needs. PCI welcomes the services of Penn Pharma.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, November/December 2014